Zura Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit

HENDERSON, Nev. --(BUSINESS WIRE)--Feb. 4, 2026-- Zura Bio Limited (Nasdaq: ZURA) (“Zura” or the “Company”), a clinical-stage biotechnology company developing novel and differentiated medicines to meaningfully improve the lives of patients with serious and debilitating autoimmune and inflammatory